Zhejiang Jiuzhou Sustainability Profile
Zhejiang Jiuzhou Pharmaceutical Co., Ltd., commonly referred to as Jiuzhou, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence in both domestic and international markets, Jiuzhou is recognised for its commitment to quality and innovation. The company’s core offerings, which include generic drugs and specialty pharmaceuticals, are distinguished by their adherence to stringent regulatory standards and advanced production techniques. Jiuzhou has achieved notable milestones, positioning itself as a trusted name in the industry, and continues to expand its market reach through strategic partnerships and a focus on research and development.
DitchCarbon Score
How does Zhejiang Jiuzhou's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Jiuzhou's score of 29 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Jiuzhou's reported carbon emissions
In 2022, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. reported total emissions of approximately 206,868,140 kg CO2e, comprising 4,621,630 kg CO2e from Scope 1 and 201,746,510 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Zhejiang Jiuzhou has set ambitious climate commitments, aiming to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2024 as the base year. Additionally, the company plans to cut Scope 3 emissions from purchased goods and services, as well as fuel- and energy-related activities, by 25% within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. The company's commitment to reducing its carbon footprint reflects a proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 3,819,730 | 0,000,000 | 0,000,000 |
| Scope 2 | 137,365,610 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Zhejiang Jiuzhou's Industry?
How Carbon Intensive is Zhejiang Jiuzhou's Location?
Zhejiang Jiuzhou's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zhejiang Jiuzhou has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Huntington Ingalls Industries
Frequently Asked Questions
Common questions about Zhejiang Jiuzhou's sustainability data and climate commitments